Public Research Library
Specialties:
Most Popular Reports:
- Laser Body Sculpting SmartLipo-Trends in Use
- Essure Permanent Birth Control
- Oral Contraceptives Market Evaluation
- Trends and Forecast of Dental Implant Cases
- Avastin and the AVADO Trial Survey
Newest Reports:
Alzheimer’s disease: current and emerging therapies
A discussion among eight neurologists specializing in the treatment of Alzheimer’s disease
Moderated by Heather Stein MD, Vice President, Research Services
October 2007
Project Objectives
Panel Intelligence engaged a panel of neurologists in a discussion designed to understand the current and emerging therapies that are used to treat Alzheimer’s disease (AD). In addition to this primary objective, the qualitative study aimed to:
§ Understand current treatment practices for mild, moderate, and severe AD
§ Discuss the use of statins in patients with AD
§ Explore the relationship between type 2 diabetes and AD
§ Review the vaccines used to treat AD
§ Evaluate emerging treatment therapies for AD including but not limited to Acceria’s Ketasyn™, Eli Lilly’s LY450139, Neurochem’s Alzehemed™, and Myriad Genetics’ Flurizan™
§ Review immunotherapy practices involved in AD treatment
Companies and Products Mentioned in This Report
|
Company |
Ticker Symbol |
Product (s) |
|
Pfizer Inc. |
PFE |
Aricept® (donepezil HCl) |
|
Eisai Inc. |
|
Aricept® (donepezil HCl) |
|
Forest Laboratories, Inc. |
FRX |
Namenda® (memantine HCl) |
|
Novartis |
NVS |
Exelon and the Exelon patch (rivastigmine tartrate) |
|
Accera, Inc. |
|
Ketasyn™ (AC-1202) |
|
Eli Lilly |
LLY |
LY450139 (gamma secretase inhibitor) |
|
Medivation, Inc. |
MDVN |
Dimebon™ |
|
Neurochem |
NRMX |
Alzehemed™ (tramiprosate) |
|
Myriad Genetics, Inc. |
MYGN |
Flurizan™ (tarenflurbil) |
|
Baxter International, Inc |
BAX |
Gammagard Liquid™ |
|
Wyeth Pharmaceuticals |
WYE |
Bapineuzumab (AAB-001) |
|
Elan Corporation |
ELN |
Bapineuzumab (AAB-001) |
Inclusion Criteria and Respondent Demographics
Neurologists who specialize in the treatment of Alzheimer’s disease
§ 8 key opinion leaders in the field of neurology and Alzheimer’s disease
§ Board-certified
§ 2 to 30 years of experience post-training
Hospitals Represented
|
Hospital/Academic Affiliation |
State |
|
Emory University School of Medicine |
GA |
|
Case Western Reserve University School of Medicine |
OH |
|
Ohio State University |
OH |
|
University of California Los Angeles |
CA |
|
Northwestern University Feinbery School of Medicine |
IL |
|
The University of Illinois at Chicago |
IL |
|
Beth Israel Deaconess Medical Center |
MA |
|
Baylor College of Medicine |
TX |
Reports become free one year after the publication date.
 about us contact us |
 |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |